# Evaluation of Blood Pressure Monitor With AFib Screening Feature

Study · id `cardio:ct-nct05599308` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05599308](<https://clinicaltrials.gov/study/NCT05599308>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05599308

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 574 participants.

## Technical summary

Registry record NCT05599308. Non-randomized; no masking; primary purpose screening. Start 2022-09-06 (actual); primary completion 2023-04-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 574 participants (enrolled count; ClinicalTrials.gov record NCT05599308, source copy `cardio:ctgov-nct05599308-2023-04-28`, retrieved 2026-10-26)
- Started: 2022-09-06 (actual) (ClinicalTrials.gov record NCT05599308, source copy `cardio:ctgov-nct05599308-2023-04-28`, retrieved 2026-10-26)
- Primary completion: 2023-04-11 (actual) (ClinicalTrials.gov record NCT05599308, source copy `cardio:ctgov-nct05599308-2023-04-28`, retrieved 2026-10-26)
- Completion: 2023-04-11 (actual) (ClinicalTrials.gov record NCT05599308, source copy `cardio:ctgov-nct05599308-2023-04-28`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05599308, source copy `cardio:ctgov-nct05599308-2023-04-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05599308-2023-04-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of Blood Pressure Monitor With AFib Screening Feature
- Condition: Atrial Fibrillation
- Intervention (Device): OMRON blood pressure monitor with AFib screening feature
- Intervention (Device): Microlife WatchBP Home A
- Lead sponsor: Omron Healthcare Co., Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: ICON plc
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as a collaborator: ICON plc (`cardio:org-icon-plc`)

## Provenance

Content hash: cd53a090b0610a13f3330e9af4252c6b5d1648c6b48409e7fcd7e39d3dc7392a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
